Viewing Study NCT05282433


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-31 @ 9:50 PM
Study NCT ID: NCT05282433
Status: UNKNOWN
Last Update Posted: 2022-03-16
First Post: 2022-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor: Zhongnan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module